Tailoring the therapeutic interventions for behavioral and psychological symptoms of dementia

References

• Gerlach LB, Kales HC. Managing behavioral and psychological symptoms of dementia. Psychiatr Clin North Am. 2018;41(1):127–139.
   PubMed Web of Science ®Google Scholar
• Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350(mar02 7):h369.
   PubMedGoogle Scholar
• Zhao QF, Tan L, Wang HF, et al. The prevalence of neuropsychiatric symptoms in Alzheimer’s disease: systematic review and meta-analysis. J Affect Disord. 2016;190:264–271.
   PubMed Web of Science ®Google Scholar
• Magierski R, Sobow T, Schwertner E, et al. Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress. Front Pharmacol. 2020;11:1168.
   PubMed Web of Science ®Google Scholar
• Lim SC. Managing behavioral and psychological symptoms of dementia - from a geriatrician’s perspective. J Aging Geriatr Psychiatry. 2018;21:1–7.
   Google Scholar
• Leung DKY, Wong KKY, Spector A, et al. Exploring dementia family carers’ self-initiated strategies in managing behavioral and psychological symptoms in dementia: a qualitative study. BMJ Open. 2021;11(8):e048761.
   PubMed Web of Science ®Google Scholar
• Finkel SI, Costa E Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr. 1996;8(Suppl 3):497–500.
   PubMedGoogle Scholar
• Burley CV, Casey AN, Chenoweth L, et al. Reconceptualizing behavioral and psychological symptoms of dementia: views of people living with dementia and families/care partners. Front Psychiatry. 2021;12:710703.
   PubMed Web of Science ®Google Scholar
• Cloak N, Khalili YA. Behavioral and psychological symptoms in dementia. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Finkel SI. Behavioral and psychologic symptoms of dementia. Clin Geriatr Med. 2003 Nov;19(4):799–824.
   PubMed Web of Science ®Google Scholar
• Scassellati C, Ciani M, Maj C, et al. Behavioral and psychological symptoms of dementia (BPSD): clinical characterization and genetic correlates in an Italian Alzheimer’s disease cohort. J Pers Med. 2020;10(3):90.
   Web of Science ®Google Scholar
• Kolanowski A, Boltz M, Galik E, et al. Determinants of behavioral and psychological symptoms of dementia: a scoping review of the evidence. Nurs Outlook. 2017;65(5):515–529.
   PubMed Web of Science ®Google Scholar
• Feast A, Orrell M, Charlesworth G, et al. Behavioral and psychological symptoms in dementia and the challenges for family carers: systematic review. Br J Psychiatry. 2016;208(5):429–434.
   PubMed Web of Science ®Google Scholar
• Kim B, Noh GO, Kim K. Behavioral and psychological symptoms of dementia in patients with Alzheimer’s disease and family caregiver burden: a path analysis. BMC Geriatr. 2021;21(1):160.
   PubMed Web of Science ®Google Scholar
• Tible OP, Riese F, Savaskan E, et al. Best practice in the management of behavioral and psychological symptoms of dementia. Ther Adv Neurol Disord. 2017;10(8):297–309.
   PubMed Web of Science ®Google Scholar
• Van der Linde RM, Dening T, Stephan BC, et al. Longitudinal course of behavioral and psychological symptoms of dementia: systematic review. Br J Psychiatry. 2016;209(5):366–377.
   PubMed Web of Science ®Google Scholar
• Rabins PV, Schwartz S, Black BS, et al. Predictors of progression to severe Alzheimer’s disease in an incidence sample. Alzheimers Dement. 2013;9(2):204–207.
   PubMed Web of Science ®Google Scholar
• Wancata J, Windhaber J, Krautgartner M, et al. The consequences of non-cognitive symptoms of dementia in medical hospital departments. Int J Psychiatry Med. 2003;33(3):257–271.
   PubMed Web of Science ®Google Scholar
• Resnick B, Galik E, Kolanowski A, et al. Gender differences in presentation and management of behavioral and psychological symptoms associated with dementia among nursing home residents with moderate to severe dementia. J Women Aging. 2020;33(1):1–18.
   Google Scholar
• Cipriani G, Lucetti C, Danti S, et al. Apathy and dementia. Nosology, assessment and management. J Nerv Ment Dis. 2014;202(10):718–724.
   PubMed Web of Science ®Google Scholar
• Fauth EB, Gibbons A. Which behavioral and psychological symptoms of dementia are the most problematic? Variability by prevalence, intensity, distress ratings, and associations with caregiver depressive symptoms. Int J Geriatr Psychiatry. 2014;29(3):263–271.
   PubMed Web of Science ®Google Scholar
• García-Alberca JM, Lara Muñoz JP, Berthier Torres M. Neuropsychiatric and behavioral symptomatology in Alzheimer disease. Actas Esp Psiquiatr. 2010;38(4):212–222.
   PubMed Web of Science ®Google Scholar
• Tampi RR, Williamson D, Muralee S, et al. Behavioral and psychological symptoms of dementia: part I—epidemiology, neurobiology, heritability, and evaluation. Clin Geriatr. 2011;19(5):41–46.
   Google Scholar
• Van der Linde RM, Stephan BCM, Savva GM, et al. Systematic reviews on behavioral and psychological symptoms in the older or demented population. Alzheimers Res Ther. 2012;4(4):28.
   PubMed Web of Science ®Google Scholar
• Fuh JL. Study of behavioral and psychological symptoms of dementia in Taiwan. Acta Neurol Taiwan. 2006;15(3):154–160.
   PubMedGoogle Scholar
• Huang S, Wang WF, Liao YC. Severity and prevalence of behavioral and psychological symptoms among patients of different dementia stages in Taiwan. Arch Clin Psychiatry. 2017;44(4):89–93.
   Web of Science ®Google Scholar
• Ismail Z, Smith EE, Geda Y, et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement. 2016;12(2):195–202.
   PubMed Web of Science ®Google Scholar
• Mortby ME, Ismail Z, Anstey KJ. Prevalence estimates of mild behavioral impairment in a population-based sample of pre-dementia states and cognitively healthy older adults. Int Psychogeriatr. 2018;30(2):221–232.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Yatabe Y, Ishikawa T, et al. Relationship between dementia severity and behavioral and psychological symptoms of dementia in dementia with lewy bodies and Alzheimer’s disease patients. Dement Geriatr Cogn Dis Extra. 2015;5(2):244–252.
   PubMedGoogle Scholar
• Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;3:73.
   PubMedGoogle Scholar
• Rockwell E, Choure J, Galasko D, et al. Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry. 2000;15(9):819–823.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Brown J, Holland AJ, et al. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2002;73(4):371–376.
   PubMed Web of Science ®Google Scholar
• Engelborghs S, Maertens K, Nagels G, et al. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry. 2005;20(11):1028–1037.
   PubMed Web of Science ®Google Scholar
• Chiu MJ, Chen TF, Yip PK, et al. Behavioral and psychologic symptoms in different types of dementia. J Formos Med Assoc. 2006;105(7):556–562.
   PubMed Web of Science ®Google Scholar
• Liu S, Jin Y, Shi Z, et al. The effects of behavioral and psychological symptoms on caregiver burden in frontotemporal dementia, Lewy body dementia, and Alzheimer’s disease: clinical experience in China. Aging Ment Health. 2017;21(6):651–657.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Biswas A, Roy A, et al. Behavioral and psychological symptoms of dementia: correlates and impact on caregiver distress. Dement Geriatr Cogn Dis Extra. 2017;7(3):354–365.
   PubMed Web of Science ®Google Scholar
• Majer R, Simon V, Csiba L, et al. Behavioral and psychological symptoms in neurocognitive disorders: specific patterns in dementia subtypes. Open Med (Wars). 2019;14(1):307–316.
   PubMedGoogle Scholar
• Köhler CA, Magalhaes TF, Oliveira JM, et al. Neuropsychiatric disturbances in mild cognitive impairment (MCI): a systematic review of population-based studies. Curr Alzheimer Res. 2016;13(10):1066–82.39.
   PubMed Web of Science ®Google Scholar
• Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk for developing dementia of Alzheimer type: A prospective color study. Arch Neurol. 2004;61(8):1290–1293.
   PubMedGoogle Scholar
• Brodaty H, Heffernan M, Draper B, et al. Neuropsychiatric symptoms in older people with and without cognitive impairment. J Alzheimers Dis. 2012;31(2):411–420.
   PubMed Web of Science ®Google Scholar
• Diniz BS, Butters MA, Albert SM, et al. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2012;202(5):329–335.
   Web of Science ®Google Scholar
• Palmer K, Berger AK, Monastero R, et al. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology. 2007;68(19):1596–1602.
   PubMed Web of Science ®Google Scholar
• Palmer K, Di Iulio F, Varsi AE, et al. Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy. J Alzheimers Dis. 2010;20(1):175–183.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee KJ, Kim H. Gender differences in behavioral and psychological symptoms of patients with Alzheimer’s disease. Asian J Psychiatr. 2017;26:124–128.
   PubMed Web of Science ®Google Scholar
• Hsieh SW, Chen CH, Huang LC, et al. Gender differences in presentation of behavioral and psychological symptoms in Alzheimer’s disease in Taiwan. Aging Ment Health. 2020;24(8):1342–1347.
   PubMed Web of Science ®Google Scholar
• Mao Y, Fisher DW, Yang S, et al. Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer’s disease. PLoS One. 2020;15(1):e0226021.
   PubMed Web of Science ®Google Scholar
• Zaudig M. Assessing behavioral symptoms of dementia of the Alzheimer type: categorical and quantitative approaches. Int Psychogeriatr. 1996;8(S2):183–200.
   PubMedGoogle Scholar
• De Deyn PP, Wirshing WC. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia. J Clin Psychiatry. 2001;62:19–22.
   PubMed Web of Science ®Google Scholar
• Auer SR, Monteiro IM, Reisberg B. The empirical behavioral pathology in Alzheimer’s disease (E-BEHAVE-AD) rating scale. Intl Psychogeriatr. 1996;8(2):247–266.
   PubMedGoogle Scholar
• Reisberg B, Auer SR, Monteiro IM. Behavioral pathology in Alzheimer’s disease (BEHAVE-AD) rating scale. Int Psychogeriatr. 1996;8:301–308.
   PubMedGoogle Scholar
• Reisberg B, Borenstein J, Franssen E, et al. BEHAVE-AD: a Clinical Rating Scale for the Assessment of Pharmacologically Remediable Behavioral Symptomatology in Alzheimer’s Disease. In: Alzheimer’s Disease: Problems, Prospects, and Perspectives, editor. Altman HJ. 1987;pp. 1–16. Boston, MA: Springer.
   Google Scholar
• Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
   PubMed Web of Science ®Google Scholar
• Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997;48(5):S10–16.
   PubMed Web of Science ®Google Scholar
• Kaufer DI, Cummings JL, Ketchel P. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233–239.
   PubMed Web of Science ®Google Scholar
• Wood S, Cummings JL, Hsu MA, et al. The use of the Neuropsychiatric Inventory in nursing home residents: characterization and measurement. Am J Geriatr Psychiatry. 2000;8(1):75–83.
   PubMed Web of Science ®Google Scholar
• De Medeiros K, Robert P, Gauthier S, et al. The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr. 2010;22(6):984–994.
   PubMed Web of Science ®Google Scholar
• Cohen-Mansfield J, Marx M, Rosenthal A. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77–M84.
   PubMedGoogle Scholar
• Kupeli N, Vickerstaff V, White N, et al. Psychometric evaluation of the Cohen-Mansfield Agitation Inventory in an acute general hospital setting. Int J Geriatr Psychiatry. 2018;33(1):e158–e165.
   PubMed Web of Science ®Google Scholar
• Bessey LJ, Walaszek A. Management of behavioral and psychological symptoms of dementia. Curr Psychiatry Rep. 2019;21(8):66.
   PubMed Web of Science ®Google Scholar
• Prior J, Abraham R, Nicholas H, et al. Are premorbid abnormal personality traits associated with behavioral and psychological symptoms in dementia? Int J Geriatr Psychiatry. 2016;31(9):1050–1055.
   PubMed Web of Science ®Google Scholar
• Zilkens RR, Bruce DG, Duke J, et al. Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65–84 years): a population based case-control study. Curr Alzheimer Res. 2014;11(7):681–693.
   PubMed Web of Science ®Google Scholar
• Ambrogio F, Martella LA, Odetti P, et al., Behavioral disturbances in dementia and beyond: time for a new conceptual frame. Int J Mol Sci. 2019;20(15):3647.
   Web of Science ®Google Scholar
• Kazui H, Yoshiyama K, Kanemoto H, et al. Differences of behavioral and psychological symptoms of dementia in disease severity in four major dementias. PLoS One. 2016;11(8):e0161092.
   PubMed Web of Science ®Google Scholar
• Minger SL, Esiri MM, McDonald B, et al. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology. 2000;55(10):1460–1467.
   PubMed Web of Science ®Google Scholar
• Engelborghs S, Vloeberghs E, Le Bastard N, et al. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochem Int. 2008;52(6):1052–1060.
   PubMed Web of Science ®Google Scholar
• Herrmann N, Lanctôt KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2004;16(3):261–276.
   PubMed Web of Science ®Google Scholar
• Flirski M, Sobow T, Kloszewska I. Behavioral genetics of Alzheimer´s disease: a comprehensive review. Arch Med Sci. 2011;7(2):195–210.
   PubMedGoogle Scholar
• Ballard CG, Gauthier S, Cummings JL, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–255.
   PubMed Web of Science ®Google Scholar
• Clare L, Wilson BA, Carter G, et al. Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions. Int J Geriatr Psychiatry. 2002;17(10):962–967.
   PubMed Web of Science ®Google Scholar
• De Vugt ME, Nicolson NA, Aalten P, et al. Behavioral problems in dementia patients and salivary cortisol patterns in caregivers. J Neuropsychiatry Clin Neurosci. 2005;17(2):201–207.
   PubMed Web of Science ®Google Scholar
• Smith M, Hall GR, Gerdner L, et al. Application of the progressively lowered stress threshold model across the continuum of care. Nurs Clin North Am. 2006;41(1):57–81.
   PubMed Web of Science ®Google Scholar
• Zuidema SU, de Jonghe JF, Verhey FR, et al. Environmental correlates of neuropsychiatric symptoms in nursing home patients with dementia. Int J Geriatr Psychiatry. 2010;25(1):14–22.
   PubMed Web of Science ®Google Scholar
• Kunik ME, Snow AL, Davila JA, et al. Consequences of aggressive behavior in patients with dementia. J Neuropsychiatry Clin Neurosci. 2010;22(1):40–47.
   PubMed Web of Science ®Google Scholar
• Clyburn LD, Stones MJ, Hadjistavropoulos T, et al. Predicting caregiver burden and depression in Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci. 2000;55(1):S2–13.
   PubMed Web of Science ®Google Scholar
• Brown SL, Smith DM, Schulz R, et al. Caregiving behavior is associated with decreased mortality risk. Psychol Sci. 2009;20(4):488‐494.
   Web of Science ®Google Scholar
• Kasuya RT, Polgar-Bailey P, Takeuchi R. Caregiver burden and burnout. A guide for primary care physicians. Postgrad Med. 2000;108(7):119–123.
   PubMed Web of Science ®Google Scholar
• Campbell P, Wright J, Oyebode J, et al. Determinants of burden in those who care for someone with dementia. Int J Geriatr Psychiatry. 2008;23(10):1078–1085.
   PubMed Web of Science ®Google Scholar
• Volicer L. Caregiver burden in dementia care: prevalence and health effects. Curr Psychos Ther Reports. 2005;3:20‐25.
   PubMedGoogle Scholar
• Vellone E, Piras G, Sansoni J. Stress, anxiety, and depression among caregivers of patients with Alzheimer’s disease. Ann Ig. 2002;14(3):223‐232.
   PubMedGoogle Scholar
• Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one’s physical health? A meta‐analysis. Psychol Bull. 2003;129(6):946‐972.
   PubMed Web of Science ®Google Scholar
• Lou Q, Liu S, Huo YR, et al. Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer’s disease. J Clin Nurs. 2015;24(17–18):2668‐2678.
   Web of Science ®Google Scholar
• Isik AT, Soysal P, Solmi M, et al., Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer’s disease: a narrative review. Int J Geriatr Psychiatry. 2019;34(9):1326–1334.
   PubMed Web of Science ®Google Scholar
• Baiyewu O, Smith-Gamble V, Akinbiyi A, et al. Behavioral and caregiver reaction of dementia as measured by the neuropsychiatric inventory in Nigerian community residents. Int Psychogeriatr. 2003;15(4):399–409.
   PubMed Web of Science ®Google Scholar
• Von Känel R, Mills PJ, Mausbach BT, et al. Effect of Alzheimer caregiving on circulating levels of C‐reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study. Gerontology. 2012;58(4):354‐365.
   PubMed Web of Science ®Google Scholar
• Steinberg M, Hess K, Corcoran C, et al. Vascular risk factors and neuropsychiatric symptoms in Alzheimer’s disease: the Cache County Study. Int J Geriatr Psychiatry. 2014;29(2):153–159.
   PubMed Web of Science ®Google Scholar
• Bruce DG, Paterson A. Barriers to community support for the dementia carer: a qualitative study. Int J Geriatr Psychiatry. 2000;15(5):451–457.
   PubMed Web of Science ®Google Scholar
• Davidsdottir SR, Snaedal J, Karlsdottir G, et al. Validation of the Icelandic version of the Neuropsychiatric Inventory with caregiver distress (NPI-D). Nord J Psychiatry. 2012;66(1):26–32.
   PubMed Web of Science ®Google Scholar
• Kosberg JI, Kaufman AV, Burgio LD, et al. Family caregiving to those with dementia in rural Alabama: racial similarities and differences. J Aging Health. 2007;19(1):3–21.
   PubMed Web of Science ®Google Scholar
• Waite A, Bebbington P, Skelton-Robinson M, et al. Social factors and depression in carers of people with dementia. Int J Geriatr Psychiatry. 2004;19(6):582–587.
   PubMed Web of Science ®Google Scholar
• Riello R, Geroldi C, Zanetti O, et al. Caregiver’s distress is associated with delusions in Alzheimer’s patients. Behav Med. 2002;28(3):92‐98.
   PubMed Web of Science ®Google Scholar
• Connors MH, Ames D, Woodward M, et al. Psychosis and clinical outcomes in Alzheimer disease: a longitudinal study. Am J Geriatr Psychiatry. 2017;26(3):304‐313.
   PubMed Web of Science ®Google Scholar
• McCurry SM, Logsdon RG, Teri L, et al. Characteristics of sleep disturbance in community-dwelling Alzheimer’s disease patients. J Geriatr Psychiatry Neurol. 1999;12(2):53–59.
   PubMed Web of Science ®Google Scholar
• Canevelli M, Lucchini F, Garofalo C, et al. Inappropriate sexual behaviors among community‐dwelling patients with dementia. Am J Geriatr Psychiatry. 2017;25(4):365‐371.
   PubMed Web of Science ®Google Scholar
• Hamel M, Gold DP, Andres D, et al. Predictors and consequences of aggressive behavior by community‐based dementia patients. Gerontologist. 1990;30(2):206‐211.
   PubMed Web of Science ®Google Scholar
• Preuss UW, Wong JWM, Koller G. Treatment of behavioral and psychological symptoms of dementia: a systematic review. Psychiatr Pol. 2016;50(4):679–715.
   PubMed Web of Science ®Google Scholar
• De Oliveira AM, Radanovic M, Cotting Homem de Mello P, et al. Nonpharmacological interventions to reduce behavioral and psychological symptoms of dementia: a systematic review. Biomed Res Int. 2015;2015:218980.
   PubMed Web of Science ®Google Scholar
• Lowery D, Cerga-Pashoja A, Iliffe S, et al. The effect of exercise on behavioral and psychological symptoms of dementia: the EVIDEM-E randomized controlled clinical trial. Int J Geriatr Psychiatry. 2014;29(8):819–827.
   PubMed Web of Science ®Google Scholar
• Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioral disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open. 2017;7(3):e012759.
   PubMed Web of Science ®Google Scholar
• Scales K, Zimmerman S, Miller SJ. Evidence-based nonpharmacological practices to address behavioral and psychological symptoms of dementia. Gerontologist. 2018;58(suppl_1):S88–S102.
   PubMed Web of Science ®Google Scholar
• Mascherona I, Ferretti M, Soldini E, et al. Essential oil therapy for the short-term treatment of behavioral and psychological symptoms of dementia: a monocentric randomized pilot study. Aging Clin Exp Res. 2021;33(8):2251–2259.
   PubMed Web of Science ®Google Scholar
• Press-Sandler O, Freud T, Volkov I, et al. Aromatherapy for the treatment of patients with behavioral and psychological symptoms of dementia: a descriptive analysis of RCTs. J Altern Complement Med. 2016;22(6):422–428.
   PubMed Web of Science ®Google Scholar
• Raglio A, Bellelli G, Traficante D, et al. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia. Alzheimer Dis Assoc Disord. 2008;22(2):158–162.
   PubMed Web of Science ®Google Scholar
• Ueda T, Suzukamo Y, Sato M, et al. Effects of music therapy on behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Aging Res Rev. 2013;12(2):628–641.
   PubMed Web of Science ®Google Scholar
• Olazarán J, Reisberg B, Clare L, et al. Nonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy. Dement Geriatr Cogn Disord. 2010;30(2):161–178.
   PubMed Web of Science ®Google Scholar
• Dyer SM, Harrison SL, Laver K, et al. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2018 Mar;30(3):295–309.
   PubMed Web of Science ®Google Scholar
• Zhou T, Wang J, Xin C, et al. Effect of memantine combined with citalopram on cognition of BPSD and moderate Alzheimer’s disease: a clinical trial. Exp Ther Med. 2019;17(3):1625–1630.
   PubMed Web of Science ®Google Scholar
• Carotenuto A, Rea R, Traini E, et al. The effect of the association between donepezil and choline alphoscerate on behavioral disturbances in Alzheimer’s disease: interim results of the ASCOMALVA trial. J Alzheimers Dis. 2017;56(2):805–815.
   PubMed Web of Science ®Google Scholar
• Chen R, Chan PT, Chu H, et al. Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer's disease: a meta-analysis. PLoS One. 2017;12(8):e0183586.
   PubMed Web of Science ®Google Scholar
• Savaskan E, Mueller H, Hoerr R, et al. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials. Int Psychogeriatr. 2018;30(3):285–293.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Kunisawa N, Shimizu S. Antipsychotic treatment of behavioral and psychological symptoms of dementia (BPSD): management of extrapyramidal side effects. Front Pharmacol. 2019;10:1045.
   PubMed Web of Science ®Google Scholar
• Wolinsky D, Drake K, Bostwick J. Diagnosis and management of neuropsychiatric symptoms in Alzheimer´s disease. Curr Psychiatry Rep. 2018;20(12):117.
   PubMed Web of Science ®Google Scholar
• Lanctôt KL, Herrmann N, Rothenburg L, et al. Behavioral correlates of GABAergic disruption in Alzheimer’s disease. Int Psychogeriatr. 2007;19(1):151–158.
   PubMed Web of Science ®Google Scholar
• Lin CH, Lane HY. The role of N-methyl-D-aspartate receptor neurotransmission and precision medicine in behavioral and psychological symptoms of dementia. Front Pharmacol. 2019;10:540.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Tsang SW, Gil-Bea FJ, et al. Involvement of the GABAergic system in depressive symptoms of Alzheimer’s disease. Neurobiol Aging. 2006;27(8):1110–1117.
   PubMed Web of Science ®Google Scholar
• Lin CH, Yang HT, Chen PK, et al. Precision medicine of sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD). Neuropsychiatr Dis Treat. 2020;16:509–518.
   PubMed Web of Science ®Google Scholar
• Lin CH, Chen PK, Wang SH, et al. Effect of sodium benzoate on cognitive function among patients with behavioral and psychological symptoms of dementia: secondary analysis of a randomized clinical trial. JAMA Network Open. 2021;4(4):e216156.
   PubMed Web of Science ®Google Scholar
• Nowrangi MA, Lyketsos CG, Rosenberg PB. Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia. Alzheimers Res Ther. 2015;7(1):1–10.
   PubMedGoogle Scholar
• Rapp MA, Schnaider-Beeri M, Grossman HT, et al. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch Gen Psychiatry. 2006;63(2):161–167.
   PubMed Web of Science ®Google Scholar
• Rapp MA, Schnaider-Beeri M, Purohit DP, et al. Increased neurofibrillary tangles in patients with Alzheimer's disease with comorbid depression. Am J Geriatr Psychiatry. 2008;16(2):168–174.
   PubMed Web of Science ®Google Scholar
• Korczyn AD, Halperin I. Depression and dementia. J Neurol Sci. 2009;283(1–2):139–142.
   PubMed Web of Science ®Google Scholar
• Lanari A, Amenta F, Silvestrelli G, et al. Neurotransmitter deficits in behavioral and psychological symptoms of Alzheimer’s disease. Mech Aging Dev. 2006;127(2):158–165.
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol. 1991;48(6):619–624.
   PubMedGoogle Scholar
• Bergener M, Finkel SI. Treating Alzheimer´s and other dementias: clinical application of recent research advances. New York (NY): Springer; 1995. Chapter 6, Biochemical, Neuropathological, and Clinical Correlations of Neurofibrillary Degeneration in Alzheimer’s Disease; p. 57–80.
   Google Scholar
• Förstl H, Burns A, Levy R, et al. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer’s disease. Br J Psychiatry. 1994;165(1):53–59.
   PubMedGoogle Scholar
• Farber NB, Rubin EH, Newcomer JW, et al. Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Arch Gen Psychiatry. 2000;57(12):1165–1173.
   PubMed Web of Science ®Google Scholar
• Sweet RA, Panchalingam K, Pettegrew JW, et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging. 2002;23(4):547–553.
   PubMed Web of Science ®Google Scholar
• Pinto T, Lanctôt KL, Herrmann N. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer’s type. Aging Res Rev. 2011;10(4):404–412.
   PubMed Web of Science ®Google Scholar
• Ismail Z, Nguyen MQ, Fischer CE, et al. Neurobiology of delusions in Alzheimer’s disease. Curr Psychiatry Rep. 2011;13(3):211–218.
   PubMed Web of Science ®Google Scholar
• Tsang SW, Francis PT, Esiri MM, et al. Loss of [3 H]4-DAMP binding to muscarinic receptors in the orbitofrontal cortex of Alzheimer’s disease patients with psychosis. Psychopharmacology (Berl). 2008;198(2):251–259.
   PubMed Web of Science ®Google Scholar
• Ballard C, Piggott M, Johnson M, et al. Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol. 2000;48(6):868–876.
   PubMed Web of Science ®Google Scholar
• Teaktong T, Piggott MA, Mckeith IG, et al. Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies. Behav Brain Res. 2005;161(2):299–305.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, et al. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer’s disease. Neuropsychologia. 2005;43(3):442–449.
   PubMed Web of Science ®Google Scholar
• Borroni B, Grassi M, Agosti C, et al. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol Aging. 2006;27(11):1595–1603.
   PubMed Web of Science ®Google Scholar
• Angelucci F, Bernardini S, Gravina P, et al. Delusion symptoms and response to antipsychotic treatment are associated with the 5-HT2A receptor polymorphism (102 T/C) in Alzheimer’s disease: a 3-year follow-up longitudinal study. J Alzheimers Dis. 2009;17(1):203–211.
   PubMed Web of Science ®Google Scholar
• Di Maria E, Bonvicini C, Bonomini C, et al. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer’s disease. J Alzheimers Dis. 2009;18(4):953–960.
   PubMed Web of Science ®Google Scholar
• Proitsi P, Lupton MK, Reeves SJ, et al. Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia. Neurobiol Aging. 2012;33(4):791–803.
   PubMed Web of Science ®Google Scholar
• Mitchell RA, Herrmann N, Lanctôt KL. The role of dopamine in symptoms and treatment of apathy in Alzheimer’s disease. CNS Neurosci Ther. 2011;17(5):411–427.
   PubMed Web of Science ®Google Scholar
• Massimo L, Powers C, Moore P, et al. Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2009;27(1):96–104.
   PubMed Web of Science ®Google Scholar
• Rosen HJ, Allison SC, Schauer GF, et al. Neuroanatomical correlates of behavioral disorders in dementia. Brain. 2005;128(11):2612–2625.
   PubMed Web of Science ®Google Scholar
• Tekin S, Mega MS, Masterman DM, et al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol. 2001;49(3):355–361.
   PubMed Web of Science ®Google Scholar
• Matthews KL, Chen CP, Esiri MM, et al. Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry. 2002;51(5):407–416.
   PubMed Web of Science ®Google Scholar
• Yesavage JA, Friedman L, Ancoli-Israel S, et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer’s disease. J Geriatr Psychiatry Neurol. 2003;16(3):131–139.
   PubMed Web of Science ®Google Scholar
• Sagud M, Nikolac Perkovic M, Vuksan-Cusa B, et al. A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment. Psychopharmacol (Berl). 2016;233(17):3259–3267.
   PubMed Web of Science ®Google Scholar
• Bishop MM, Fixen DR, Linnebur SA, et al. Cognitive effects of vortioxetine in older adults: a systematic review. Ther Adv Psychopharmacol. 2021;11:20451253211026796.
   Web of Science ®Google Scholar
• Scuteri D, Corasaniti MT, Tonin P, et al. New trends in pharmacological control of neuropsychiatric symptoms of dementia. Curr Opin Pharmacol. 2021;61:69–76.
   PubMed Web of Science ®Google Scholar
• Kwon CY, Lee B. Herbal medicine for behavioral and psychological symptoms of dementia: a systematic review and meta-analysis. Front Pharmacol. 2021;12:713287.
   PubMed Web of Science ®Google Scholar